QFK-27124-98828
3 vaccinations
2 coded responses
35 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 381 / TN
- Registered
- 2021-02-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-02-26
Registered in v-safe
-
2021-02-26
Dose 1 — Pfizer-BioNTech
- 2021-02-26
-
2021-02-27
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-12
-
2021-03-19
Dose 2 — Pfizer-BioNTech
- 2021-03-19
-
2021-03-20
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-21
- 2021-03-22
- 2021-03-24
- 2021-03-25
- 2021-03-28
- 2021-04-02
- 2021-04-11
- 2021-04-18
- 2021-04-23
- 2021-06-18
- 2021-09-19
-
2021-12-27
Dose 3 — Moderna
- 2021-12-27
- 2021-12-28
- 2021-12-29
- 2021-12-31
- 2022-01-01
- 2022-01-02
- 2022-01-03
- 2022-01-10
- 2022-01-17
- 2022-01-26
- 2022-03-28
-
2022-06-27
Survey response — 6 months, dose 3MedDRA: Pharyngitis streptococcal — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Strep throatMedDRA releases: 2024-11 · check-in free text available
-
2022-06-27
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-06-28
Call successfulNot applicable - Accidental Reporting
-
2022-12-29
Survey response — 12 months, dose 3MedDRA: Influenza, Sinusitis, Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Influenza-A, sinus infection, upper respiratory infection.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-29
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-12-30
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-26 | Pfizer-BioNTech | |
| 2 | 2021-03-19 | Pfizer-BioNTech | |
| 3 | 2021-12-27 | Moderna | No |
Call center
2 call center cases
2 successful
Free text
Release 12 — 6 months, dose 3
Symptoms: Strep throat
Release 12 — 12 months, dose 3
Symptoms: Influenza-A, sinus infection, upper respiratory infection.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Influenza | · | · | ✓ |
| SD | Pharyngitis streptococcal | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release